Co-occurring Eating and Substance Use Disorders
Eating Disorders and Substance Use Disorder share many risk factors and characteristics, but there are significant differences in the path to recovery for clients. Explore the similarities and differences while learning how to effectively identify and intervene when eating disorders and substance use disorders co-occur. With this improved understanding you can better help your clients end their war with food and substances.
About the Presenters
Alison Sharpe-Havill, PsyD, LP
Alison Sharpe-Havill, PsyD, LP, received her doctorate in clinical health psychology from the Minnesota School of Professional Psychology at Argosy University in 2010. She joined the outpatient Melrose Center team in 2016. Her experience as the Mental Health Services Director at Park Avenue Center serves her well when working with clients with co-occurring eating disorders and substance abuse at Melrose Center. She draws on cognitive behavioral and interpersonal therapy as well as mindfulness meditation traditions to help clients understand how the body, mind and spirit work together to create wellness.
Andrea Zuellig, PhD, LP
Andrea Zuellig, PhD, LP, received her doctorate in clinical psychology from Pennsylvania State University in 2002. She has specialized in treating patients with eating disorders for more than 14 years as a licensed psychologist at Melrose Center. She currently conducts psychotherapy with individuals, families, and groups in the higher level of care treatment programs (intensive residential, residential and partial hospitalization program) as well as in the Melrose outpatient intensive eating disorder and substance abuse program. Dr. Zuellig has been intensively trained in dialectical behavior therapy (DBT) and uses this evidence based treatment model with patients with co-occurring eating disorders and substance use disorder. She has also received training and group supervision with Christopher Fairburn, DM, in CBT-E, an enhanced cognitive behavioral therapy particularly designed for treatment of eating disorders.